Australia & New Zealand Musculoskeletal (Anzmusc) Clinical Trials Network

Grant number: 1134856 | Funding period: 2018 - 2022

Completed

Abstract

Arthritis and musculoskeletal conditions place an immense and growing burden on the world’s population. They affect 28% of Australians (>6.1 million people). With the support of CRE funding, the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network will optimise musculoskeletal health through high quality, collaborative clinical research, building research capacity and effective transfer of research outcomes into clinical practice and health policy.

Related publications (1)

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)

WJ Taylor, R Willink, DA O Connor, V Patel, A Bourne, IA Harris, SL Whittle, B Richards, O Clavisi, S Green, RS Hinman, CG Maher, A Cahill, A McPherson, C Hewson, SE May, B Walker, PC Robinson, D Ghersi, J Fitzpatrick

2023-03-01

High quality clinical research that addresses important questions requires significant resources. In resource-constrained environm..

University of Melbourne Researchers

Rana Hinman